These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31215364)

  • 1. Hot-Melt Preparation of a Non-Biodegradable Peptide Implant: A Proof of Principle.
    D'Hondt M; Verbeke F; Wuytens P; Skirtach A; De Spiegeleer B; Wynendaele E
    Protein Pept Lett; 2019; 26(9):691-701. PubMed ID: 31215364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
    Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
    Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin.
    Duque L; Körber M; Bodmeier R
    Int J Pharm; 2018 Mar; 538(1-2):139-146. PubMed ID: 29355654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
    Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
    J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
    Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
    [No Abstract]   [Full Text] [Related]  

  • 10. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
    Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
    J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
    Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
    Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry heat forced degradation of buserelin peptide: kinetics and degradant profiling.
    D'Hondt M; Fedorova M; Peng CY; Gevaert B; Taevernier L; Hoffmann R; De Spiegeleer B
    Int J Pharm; 2014 Jun; 467(1-2):48-9. PubMed ID: 24657556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from melt-extrudates through processing parameters: a chemometric approach.
    Sarraf AG; Cherkaoui S; Jordan O; Gurny R; Doelker E
    Int J Pharm; 2015 Mar; 481(1-2):9-17. PubMed ID: 25543111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
    Kalivoda A; Fischbach M; Kleinebudde P
    Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
    Sawant KP; Fule R; Maniruzzaman M; Amin PD
    Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.